Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 14 of 100
Commentary
It’s time for facts in the PBM debate
By
David Joyner
April 3, 2024
Newsletters
Johnson & Johnson CIO says employee upskilling is key to transforming health care
By
John Kell
April 3, 2024
Health
‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule
By
Maia Anderson
,
Healthcare Brew
and
Morning Brew
March 30, 2024
Retail
Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By
Sasha Rogelberg
March 29, 2024
Commentary
The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
By
Howard Dean
March 28, 2024
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By
Madison Muller
,
Robert Langreth
and
Bloomberg
March 28, 2024
Leadership
China woos CEOs of Apple, chipmakers, pharma giants as geopolitical tensions mount: ‘The risk-reward has changed’
By
Bloomberg
March 23, 2024
Commentary
Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
By
Bill Anderson
March 21, 2024
Life
An exercise pill may soon offer the same benefits as a workout, scientists say
By
Lindsey Leake
March 18, 2024
Newsletters
How AI turbocharged the development of a new drug and what it might mean for health care
By
Diane Brady
March 14, 2024
Health
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
By
Tom Murphy
,
Matthew Perrone
and
The Associated Press
March 8, 2024
Health
Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big
By
Lindsey Leake
March 8, 2024
Health
Bayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’
By
Ryan Hogg
March 6, 2024
Retail
Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By
Niclas Rolander
and
Bloomberg
March 5, 2024
Health
Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
By
Lindsey Leake
March 5, 2024
Most Popular
Success
‘I don’t know why I need to go to college’: Ford CEO says his Gen Z son worked as a mechanic and wondered if the 4-year...
By
Nick Lichtenberg
AI
'We are going to destroy jobs faster than we can replace them': The CEO whose 80% stock plunge personified the dotcom...
By
Michael Liedtke
and
The Associated Press
Success
Gen Z billionaire Alexandr Wang tells 13-year-olds they should be more like Bill Gates, who snuck out of the house to...
By
Jessica Coacci